Core 4.0

C-PMI 1-5: Quality Management Program Evaluation

Submited by: Tom Goddard

The Basics

This standard both requires that your organization conduct an annual evaluation of the effectiveness of your QM program and describes the required components of that evaluation, which must be provided to the leadership at least annually. The required components include:

  • Recommendations to leadership on how to improve the QM program;
  • An analysis of the organization's performance as compared to the organization's goals for performance;
  • A finding of whether the staff and technical resources available for the QM program were sufficient;
  • Whether the people involved in the QM program were the right people to be involved; and
  • An impact assessment of the QM program.

Management Tips

First, we recommend that your report track the requirements of this standard. Clearly label each section of the evaluation report using language that corresponds closely to URAC's language, making it easier for the reviewer to recognize the report's compliance with the standard.
Second, keep in mind that this evaluation has, at its core, the underlying purpose of providing leadership with ideas that answer not only how the organization is doing in terms of QM but also what it should do in order to improve its performance. 
Impact, in this context, simply looks at the question of whether the QM program made a difference.

Accreditation Tips

Desktop Review
Submit your QM program description, a template of your QM program evaluation report, and meeting minutes demonstrating compliance with this standard. 
Validation Review
Interviews
The URAC reviewer will talk with both leadership and QM staff about both the effectiveness of the program and how that effectiveness is evaluated.
Document review
The reviewer will examine QM evaluation reports, QMC meeting minutes, and other documentation of program evaluation.

  • Mail Service Pharmacy 4.0 / 01.07.2020

    OPS 5-1: Prescription Order Review

    This standard requires your pharmacy to implement written P&Ps addressing:Verification of the prescription source;The legibility of the prescription (and if it is illegibility, activities to clarify the prescription);A drug utilization mechanism that addresses the full array of DrUM considerations; Communication with the prescriber and patient, as appropriate, to resolve any discrepancies regardin...

    READ FULL POST
  • Specialty Pharmacy 4.0 / 01.07.2020

    OPS 5-1: Prescription Order Review

    This standard requires your pharmacy to implement written P&Ps addressing:Verification of the prescription source;The legibility of the prescription (and if it is illegibility, activities to clarify the prescription);A drug utilization mechanism that addresses the full array of DrUM considerations; Communication with the prescriber and patient, as appropriate, to resolve any discrepancies regardin...

    READ FULL POST
  • Specialty Pharmacy 4.0 / 01.07.2020

    OPS 4-3: Manufacturer and FDA Requirements

    The focus of this standard is compliance. First, the pharmacy must have a clear process for identifying and implementing applicable regulatory and manufacturer requirements (including FDA Risk Evaluation and Mitigation Strategy - "REMS" requirements). Second, the pharmacy must implement mechanisms to ensure that the staff complies with those requirements.Finally, the pharmacy must implement a mech...

    READ FULL POST
Top